City University of New York, School of Public Health

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, City University of New York, School of Public Health sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials 2 currently recruiting 7 completed top decile by trial count

City University of New York, School of Public Health: 10 sponsored US clinical trials, 2 recruiting.

City University of New York, School of Public Health sponsors 10 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 7 completed. The most-studied condition in this pipeline is Test Acceptability/Usability of a Physical Activity App Developed for African American Women, with 1 trials.

Top-decile sponsor footprint

City University of New York, School of Public Health ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the City University of New York, School of Public Health pipeline

2 recruiting of 10 indexed (20% open); 7 completed (70%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Test Acceptability/Usability of a Physical Activity App Developed for African American Women (1 trial), 5 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

City University of New York, School of Public Health: open-pipeline peers nationwide

Peers matched on 10 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

City University of New York, School of Public Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 4681012 0%10%20%30%40% Total trials Recruiting share City University of New York, School of Public HealthAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron PharmaceuticalsAcera SurgicalAlign TechnologyAltruBioAlvernia University
City University of New York, School of Public Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

City University of New York, School of Public Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

What to do with this City University of New York, School of Public Health page

10 registered trials is a research-attention snapshot, not an endorsement of City University of New York, School of Public Health or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

City University of New York, School of Public Health pipeline card: 10 registered trials from official public datasets.Report a data error.